Clinical Trial Update: Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of Vactosertib in adolescents and adults with recurrent, refractory, or progressive osteosarcoma; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Vactosertib (Vactosertib)

Snippet

Sponsor: MedPacto, Inc. | Conditions: Osteosarcoma | Phase 1, Phase 2 | Status: RECRUITING